Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers.
Rickles-Young M, Tinoco G, Tsuji J, Pollock S, Haynam M, Lefebvre H, Glover K, Owen DH, Collier KA, Ha G, Adalsteinsson VA, Cibulskis C, Lennon NJ, Stover DG. Rickles-Young M, et al. Among authors: owen dh. J Mol Diagn. 2024 May;26(5):413-422. doi: 10.1016/j.jmoldx.2024.01.014. Epub 2024 Mar 13. J Mol Diagn. 2024. PMID: 38490303 Free article.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
Spakowicz D, Hoyd R, Muniak M, Husain M, Bassett JS, Wang L, Tinoco G, Patel SH, Burkart J, Miah A, Li M, Johns A, Grogan M, Carbone DP, Verschraegen CF, Kendra KL, Otterson GA, Li L, Presley CJ, Owen DH. Spakowicz D, et al. Among authors: owen dh. BMC Cancer. 2020 May 6;20(1):383. doi: 10.1186/s12885-020-06882-6. BMC Cancer. 2020. PMID: 32375706 Free PMC article.
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Haddad TC, Zhao S, Li M, Patel SH, Johns A, Grogan M, Lopez G, Miah A, Wei L, Tinoco G, Riesenberg B, Li Z, Meara A, Bertino EM, Kendra K, Otterson G, Presley CJ, Owen DH. Haddad TC, et al. Among authors: owen dh. Cancer Immunol Immunother. 2022 May;71(5):1157-1165. doi: 10.1007/s00262-021-03068-2. Epub 2021 Oct 7. Cancer Immunol Immunother. 2022. PMID: 34618180 Free PMC article.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Miah A, Tinoco G, Zhao S, Wei L, Johns A, Patel S, Li M, Grogan M, Lopez G, Husain M, Hoyd R, Mumtaz K, Meara A, Bertino EM, Kendra K, Spakowicz D, Otterson GA, Presley CJ, Owen DH. Miah A, et al. Among authors: owen dh. J Cancer Res Clin Oncol. 2023 May;149(5):2235-2242. doi: 10.1007/s00432-022-04340-3. Epub 2022 Sep 7. J Cancer Res Clin Oncol. 2023. PMID: 36070148 Free PMC article. Review.
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Li M, Zhao S, Lopez G, Secor A, Das P, Surya N, Grogan M, Patel S, Chakravarthy K, Miah A, Spakowicz D, Tinoco G, Li Z, Wei L, He K, Bertino E, Alahmadi A, Memmott R, Kaufman J, Shields PG, Carbone DP, Presley CJ, Otterson GA, Owen DH. Li M, et al. Among authors: owen dh. Cancer Immunol Immunother. 2023 Jul;72(7):2067-2074. doi: 10.1007/s00262-023-03392-9. Epub 2023 Feb 16. Cancer Immunol Immunother. 2023. PMID: 36795122 Free PMC article.
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.
Baek J, Owen DH, Merritt RE, Shilo K, Otterson GA, D'Souza DM, Carbone DP, Kneuertz PJ. Baek J, et al. Among authors: owen dh. Clin Lung Cancer. 2020 Jul;21(4):e265-e269. doi: 10.1016/j.cllc.2020.02.016. Epub 2020 Feb 25. Clin Lung Cancer. 2020. PMID: 32184051 No abstract available.
129 results